The Supreme Court’s judgment pushes the conversation in the right direction, but it does not resolve the full range of structural issues that determine how tribunals work on the ground.
Advice comes at a time when India accounts for a 5th of global generic drug supply & 40% of generics used in US. However, this strength in finished formulations relies on imported ingredients.
It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.
COMMENTS